BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35193475)

  • 1. Personalized functional profiling using
    Kim H; El-Khoury V; Schulte N; Zhan T; Betge J; Cousin L; Felli E; Pessaux P; Ogier A; Opitz O; Ku B; Ebert MP; Kwon YJ
    Cancer Biol Ther; 2022 Dec; 23(1):96-102. PubMed ID: 35193475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular pathogenesis and management of bronchial carcinoids.
    Cakir M; Grossman A
    Expert Opin Ther Targets; 2011 Apr; 15(4):457-91. PubMed ID: 21275849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [CT and MRI findings of primary hepatic neuroendocrine neoplasm].
    Li JK; Wang M; Yuan J; Song ZG
    Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):600-606. PubMed ID: 28835083
    [No Abstract]   [Full Text] [Related]  

  • 4. Atypical course of typical lung carcinoid.
    Jakubíková L
    Klin Onkol; 2020; 33(4):302-308. PubMed ID: 32894960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
    Swarts DR; Ramaekers FC; Speel EJ
    Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].
    Langfort R; Rudziński P; Burakowska B
    Pneumonol Alergol Pol; 2010; 78(1):33-46. PubMed ID: 20162517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification and Pathology of Lung Cancer.
    Zheng M
    Surg Oncol Clin N Am; 2016 Jul; 25(3):447-68. PubMed ID: 27261908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The single-cell transcriptional landscape of lung carcinoid tumors.
    Bischoff P; Trinks A; Wiederspahn J; Obermayer B; Pett JP; Jurmeister P; Elsner A; Dziodzio T; Rückert JC; Neudecker J; Falk C; Beule D; Sers C; Morkel M; Horst D; Klauschen F; Blüthgen N
    Int J Cancer; 2022 Jun; 150(12):2058-2071. PubMed ID: 35262195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress in clinicopathological studies of pulmonary neuroendocrine neoplasm with atypical carcinoid morphology and elevated mitotic count].
    Zhang Y; Jiang LL
    Zhonghua Bing Li Xue Za Zhi; 2022 Mar; 51(3):281-286. PubMed ID: 35249303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine tumors (carcinoid and neuroendocrine carcinoma) presenting at extra-appendiceal sites in childhood and adolescence.
    Broaddus RR; Herzog CE; Hicks MJ
    Arch Pathol Lab Med; 2003 Sep; 127(9):1200-3. PubMed ID: 12946222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances in the Management of Typical and Atypical Lung Carcinoids.
    Prinzi N; Rossi RE; Proto C; Leuzzi G; Raimondi A; Torchio M; Milione M; Corti F; Colombo E; Prisciandaro M; Cascella T; Spreafico C; Beninato T; Coppa J; Lo Russo G; Di Bartolomeo M; de Braud F; Pusceddu S
    Clin Lung Cancer; 2021 May; 22(3):161-169. PubMed ID: 33618994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic Neuroendocrine Neoplasms to the Pancreas: Two Unusual Cases and a Review of the Literature.
    DelBaugh RM; Kerr DA; Dominguez-Konicki L; Beard JA; Gordon SR; Adler JM; Liu X
    Int J Surg Pathol; 2024 May; 32(3):523-532. PubMed ID: 37461216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the Diagnosis and Management of Well-Differentiated and Intermediate-Differentiated Neuroendocrine Tumors of the Lung.
    Wolin EM
    Chest; 2017 May; 151(5):1141-1146. PubMed ID: 27373769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of lung neuroendocrine neoplasm classification.
    Metovic J; Barella M; Harari S; Pattini L; Albini A; Sonzogni A; Veronesi G; Papotti M; Pelosi G
    Expert Rev Anticancer Ther; 2021 Apr; 21(4):377-387. PubMed ID: 33306420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular markers help characterize neuroendocrine lung tumors.
    Rusch VW; Klimstra DS; Venkatraman ES
    Ann Thorac Surg; 1996 Sep; 62(3):798-809; discussion 809-10. PubMed ID: 8784011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary Neuroendocrine Tumors.
    Borczuk AC
    Surg Pathol Clin; 2020 Mar; 13(1):35-55. PubMed ID: 32005434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide Receptor Radionuclide Therapy for Patients With Advanced Lung Carcinoids.
    Naraev BG; Ramirez RA; Kendi AT; Halfdanarson TR
    Clin Lung Cancer; 2019 May; 20(3):e376-e392. PubMed ID: 30910575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical management of atypical carcinoid and large-cell neuroendocrine carcinoma: a multicentre study on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours of the Lung Working Group†.
    Filosso PL; Rena O; Guerrera F; Moreno Casado P; Sagan D; Raveglia F; Brunelli A; Welter S; Gust L; Pompili C; Casadio C; Bora G; Alvarez A; Zaluska W; Baisi A; Roesel C; Thomas PA;
    Eur J Cardiothorac Surg; 2015 Jul; 48(1):55-64. PubMed ID: 25406425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pulmonary tumorlet associated with second neoplasia].
    Pitzzu M; Ferreira Y; Sánchez MC; Saccoliti M; Spizzamiglio N; Galmes M; Abalovich M; O'Leary K; Jankilevich G
    Medicina (B Aires); 2017; 77(4):341-343. PubMed ID: 28825583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic therapy for pulmonary carcinoids.
    Marquez-Medina D; Popat S
    Lung Cancer; 2015 Nov; 90(2):139-47. PubMed ID: 26371699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.